AndreaBozzo/ceres-open-data-index huggingface dataset:
Video Series on Data Driven Decision Making

This first part of the video series on data-driven decision making (DDDM) provides an overview of DDDM, explains its importance in the context of human service organizations, and describes the process of developing a theory of change as a first step in the DDDM process in the context of a fictional human services organization (Greene County Department of Human Services).

This second part of the DDDM video series explores the process of collecting and analyzing data to inform decision making in a human service context. Using the fictional example of Greene County Department of Human Services’ foster care recruitment and licensing program, the video describes the creation of data collection and tracking systems, the monitoring of ongoing recruitment and licensing activities, and using data to identify and troubleshoot problems.

This third and final part of the DDDM video series describes strategies for communicating information collected through the DDDM process to key stakeholder groups in a clear and concise manner and for using findings to solve problems and make program improvements. The fictional example of Greene County Department of Human Services’ foster care recruitment and licensing program is used again to illustrate these strategies.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527752: 2,2-Dichloroethyl butanoate

Chemical compound data from PubChem database. IUPAC Name: 2,2-dichloroethyl butanoate. Molecular Formula: C6H10Cl2O2. Molecular Weight: 185.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530192: Imidazole-5-lactic acid, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-(3-trimethylsilylimidazol-4-yl)-2-trimethylsilyloxypropanoate. Molecular Formula: C15H32N2O3Si3. Molecular Weight: 372.68. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525366: 2,3-Dimethyl-4-thiaoctane

Chemical compound data from PubChem database. IUPAC Name: 2-butylsulfanyl-3-methylbutane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 529944: 1-(Thiophen-3-yl)propan-1-one

Chemical compound data from PubChem database. IUPAC Name: 1-thiophen-3-ylpropan-1-one. Molecular Formula: C7H8OS. Molecular Weight: 140.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Reporting of adverse drug reactions in randomised controlled trials – a systematic survey

Background
          Decisions on treatment are guided, not only by the potential for benefit, but also by the nature and severity of adverse drug reactions. However, some researchers have found numerous deficiencies in trial reports of adverse effects. We sought to confirm these findings by evaluating trials of drug therapy published in seven eminent medical journals in 1997.
        
        
          Methods
          Literature review to determine whether the definition, recording and reporting of adverse drug reactions in clinical trials were in accordance with published recommendations on structured reporting.
        
        
          Results
          Of the 185 trials reviewed, 25 (14%) made no mention of adverse drug reactions. Data in a further 60 (32%) could not be fully evaluated, either because numbers were not given for each treatment arm (31 trials), or because a generic statement was made without full details (29 trials). When adverse drug reactions such as clinical events or patient symptoms were mentioned in the reports, details on how they had been recorded were given in only 14/95 (15%) and 18/104 (17%) trials respectively. Of the 86 trials that mentioned severity of adverse drug reactions, only 42 (49%) stated how severity had been defined. The median amount of space used for safety data in the Results and Discussion sections was 5.8%.
        
        
          Conclusions
          Trial reports often failed to provide details on how adverse drug reactions were defined or recorded. The absence of such methodological information makes comparative evaluation of adverse reaction rates potentially unreliable. Authors and journals should adopt recommendations on the structured reporting of adverse effects.
Gene discovery within the planctomycete division of the domain Bacteria using sequence tags from genomic DNA libraries

Background
          The planctomycetes comprise a distinct group of the domain Bacteria, forming a separate division by phylogenetic analysis. The organization of their cells into membrane-defined compartments including membrane-bounded nucleoids, their budding reproduction and complete absence of peptidoglycan distinguish them from most other Bacteria. A random sequencing approach was applied to the genomes of two planctomycete species, Gemmata obscuriglobus and Pirellula marina, to discover genes relevant to their cell biology and physiology.
        
        
          Results
          Genes with a wide variety of functions were identified in G. obscuriglobus and Pi. marina, including those of metabolism and biosynthesis, transport, regulation, translation and DNA replication, consistent with established phenotypic characters for these species. The genes sequenced were predominantly homologous to those in members of other divisions of the Bacteria, but there were also matches with nuclear genomic genes of the domain Eukarya, genes that may have appeared in the planctomycetes via horizontal gene transfer events. Significant among these matches are those with two genes atypical for Bacteria and with significant cell-biology implications - integrin alpha-V and inter-alpha-trypsin inhibitor protein - with homologs in G. obscuriglobus and Pi. marina respectively.
        
        
          Conclusions
          The random-sequence-tag approach applied here to G. obscuriglobus and Pi. marina is the first report of gene recovery and analysis from members of the planctomycetes using genome-based methods. Gene homologs identified were predominantly similar to genes of Bacteria, but some significant best matches to genes from Eukarya suggest that lateral gene transfer events between domains may have involved this division at some time during its evolution.
Compound 530512: 2-Chlorobenzoic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 2-chlorobenzoate. Molecular Formula: C19H23ClO2. Molecular Weight: 318.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2015 CMHS Uniform Reporting System (URS) Table for Republic of Marshall Islands

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Republic of Marshall Islands. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528214: Benzoic acid, 2-hydroxy-6-methyl-3-(1,1-dimethylethyl), DTBS

Chemical compound data from PubChem database. IUPAC Name: 2,2,8-tritert-butyl-5-methyl-1,3,2-benzodioxasilin-4-one. Molecular Formula: C20H32O3Si. Molecular Weight: 348.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Miami - Fort Lauderdale Div: Drug-Related Emergency Department Visits, 2008-2011 - Seeking Detox

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving patients seeking detox in the Fort Lauderdale division of the Miami metropolitan area, covering 2008-2011. This includes nonemergency requests made through the ED for admission to detoxification unit, visits to obtain medical clearance before being incarcerated, and acute emergencies where an individual is experiencing withdrawal symptoms and requests detox. These estimates do not include patients who seek or enter the hospital\'s detox unit through other avenues.
Patent AT-E400924-T1: [Translated] METHOD FOR DYNAMIC SYMMETIZATION OF SERIES AND PARALLEL-CONNECTED POWER SEMICONDUCTOR SWITCHES

A method for dynamically balancing the loads in a circuit ( 1, 4 ) of semiconductor power switches arranged in series or in parallel is disclosed. Individual switching signals (i<SUB>G1</SUB>, i<SUB>G2</SUB>) for the semiconductor power switches (S<SUB>1 </SUB>. . . S<SUB>4</SUB>) are generated by determining a system-widely valid synchronous sampling time (ts<SUB>j</SUB>) independently for each semiconductor power switch (S<SUB>1 </SUB>. . . S<SUB>4</SUB>) due to a synchronous event (es) of the whole circuit ( 1, 4 ). Control loop offsets between actual values (a<SUB>i</SUB>) measured synchronously at the sampling time (ts<SUB>j</SUB>) and given desired values (a<SUB>s</SUB>) of an asynchronous state variable (a(t)) of the semiconductor power switches (S<SUB>1 </SUB>. . . S<SUB>4</SUB>) are reduced in the same or in following switching cycles. Alternatively, control loop offsets between actual time values (ta<SUB>i</SUB>) and desired time values (ta<SUB>s</SUB>) are minimized, wherein the actual time values (ta<SUB>i</SUB>) are measured upon exceeding a globally provided threshold value (epsilon<SUB>a</SUB>) of an asynchronous state variable (a(t)) of the semiconductor power switches (S<SUB>1 </SUB>. . . S<SUB>4</SUB>). Embodiments relate to: Offsetting the sampling time (ts<SUB>j</SUB>) in time by a globally provided time interval (Deltat 0 ), providing desired values locally or globally, e.g. by averaging of actual values (a<SUB>i</SUB>, ta<SUB>i</SUB>), additional balancing of the gradients of asynchronous time variables (a(t)). A central sampling command can be dispensed with and the switching synchronicity is improved, switching times are shortened and dynamic switching losses are reduced.
San Francisco – SF Div: Drug-Related Emergency Department Visits, 2004-2011 - All Alcohol

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving alcohol in the San Francisco division of the San Francisco metropolitan area.  For adults aged 21 and older, the alcohol was found in combination with other drugs. For patients under the age of 21, the visit may involve alcohol alone or in combination with other drugs.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 528854: 5-Ethyl-7-pentyl-1,2,3,4,6-pentathiepane

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-7-pentyl-1,2,3,4,6-pentathiepane. Molecular Formula: C9H18S5. Molecular Weight: 286.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529796: Leucine, trifluoroacetyl-isopropyl ester

Chemical compound data from PubChem database. IUPAC Name: propan-2-yl 4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentanoate. Molecular Formula: C11H18F3NO3. Molecular Weight: 269.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528216: Benzoic acid, 3,4-dihydroxy, methyl ester, DTBS

Chemical compound data from PubChem database. IUPAC Name: methyl 2,2-ditert-butyl-1,3,2-benzodioxasilole-5-carboxylate. Molecular Formula: C16H24O4Si. Molecular Weight: 308.44. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Irbesartan and hydrochlorothiazide

Irbesartan and Hydrochlorothiazide is a prescription medication combining an angiotensin II receptor blocker and a thiazide diuretic to treat high blood pressure. Available in tablets: 150mg irbesartan/12.5mg hydrochlorothiazide and 300mg irbesartan/12.5mg hydrochlorothiazide. Manufactured by Hisun Pharmaceuticals USA Inc. under ANDA 207896. This information was generated using AI and is provided for informational and research purposes only.
Network PUF - PY2018

The Network PUF (Ntwrk-PUF) is one of the seven files that make up the Marketplace PUF. The Ntwrk-PUF contains issuer-level data identifying provider network URLs. These data either originate from the Network ID template (i.e., template field), an Excel based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated)
2013 CMHS Uniform Reporting System (URS) Table for New Mexico

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for New Mexico for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 529031: Oxazole, 4-ethyl-5-methyl

Chemical compound data from PubChem database. IUPAC Name: 4-ethyl-5-methyl-1,3-oxazole. Molecular Formula: C6H9NO. Molecular Weight: 111.14. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2021 Final Assisted Reproductive Technology (ART) Summary

Data were updated on September 11, 2024.

ART data are made available as part of the National ART Surveillance System (NASS) that collects success rates, services, profiles and annual summary data from fertility clinics across the U.S. There are four datasets available: ART Services and Profiles, ART Patient and Cycle Characteristics, ART Success Rates, and ART Summary. All four datasets may be linked by “ClinicID.” ClinicID is a unique identifier for each clinic that reported cycles. The Summary dataset provides a full snapshot of clinic services and profile, patient characteristics, and ART success rates. It is worth noting that patient medical characteristics, such as age, diagnosis, and ovarian reserve, affect ART treatment’s success. Comparison of success rates across clinics may not be meaningful because of differences in patient populations and ART treatment methods. The success rates displayed in this dataset do not reflect any one patient’s chance of success. Patients should consult with a doctor to understand their chance of success based on their own characteristics.
2012 Uniform Reporting System (URS) Tables for District of Columbia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 525132: 2,4,5-Trimethoxy-6-(methoxymethyl)-3-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane

Chemical compound data from PubChem database. IUPAC Name: 2,4,5-trimethoxy-6-(methoxymethyl)-3-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane. Molecular Formula: C20H38O11. Molecular Weight: 454.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400737-T1: [Translated] STARTING DEVICE FOR AN INTERNAL COMBUSTION ENGINE

The invention relates to a starter device (160) for an internal combustion engine, comprising a starter motor (140) and a switching control device for controlling the starter motor (140). The latter comprises a power switching module (165,170, 175, 180) connecting the starter motor (140) to a voltage source (130). The switching control device also comprises a control electronics system (195) used to control the power switching module (165,170, 175, 180), and an actuating device (135) used to activate the control electronics system (195). The control electronics system (195) is configured in such a way that it can be operated with a supply voltage which is less than 5V, thereby ensuring safe operation of the starter device even if the supply voltage falls off in the wake of the starting process.
Compound 525680: N-(4-Chlorobenzylidene)-M-toluidine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-chlorophenyl)-N-(3-methylphenyl)methanimine. Molecular Formula: C14H12ClN. Molecular Weight: 229.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528870: Methyl 3,4-dimethyl-2-thienyl disulfide

Chemical compound data from PubChem database. IUPAC Name: 3,4-dimethyl-2-methylsulfanylthiophene. Molecular Formula: C7H10S2. Molecular Weight: 158.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530464: o-Toluic acid, 1-adamantylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: 1-adamantylmethyl 2-methylbenzoate. Molecular Formula: C19H24O2. Molecular Weight: 284.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.